Clinical Trials Update: Sept. 14, 2006
Parkinson's Disease Generalized Anxiety Disorder (GAD) Smoking Cessation or Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will test a computerized device that can be used at home to measure Parkinson's disease symptoms. Volunteers may be eligible to participate if they have a Parkinson's diagnosis of less than five years with at least two of the following symptoms: rest tremor, bradykinesia, or rigidity.
The research site is in Los Angeles, Calif.
Generalized Anxiety Disorder (GAD)
This outpatient study of an investigational drug is for volunteers 18-65 with symptoms of generalized anxiety disorder. Common symptoms include: feeling worried or anxious, being easily fatigued or irritable, and having difficulty concentrating or sleeping. Study participation will last approximately three months, including weekly clinic visits.
The research site is in Wildomar, Calif.
Smoking Cessation or Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
This pilot study will evaluate how well osmotic release methylphenidate promotes smoking abstinence in people with attention deficit hyperactivity disorder (ADHD). Candidates may be included who want to quit smoking, are 18-55 years old, and are easily distracted, forgetful, impulsive, and/or fidgety.
The research site is in New York City.
Copyright 2006 Thomson CenterWatch. All rights reserved.